Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Earnings symbols : Hznp save search
Horizon Therapeutics plc Reports Fourth-Quarter and Full-Year 2022 Financial Results
Published: 2023-03-01 (Crawled : 14:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: 0.0%
H: 0.91%
C: 0.78%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.56%
H: 2.63%
C: 2.53%
therapeutics financial results
Horizon Therapeutics plc Reports Third-Quarter 2022 Financial Results; Increases Full-Year 2022 Net Sales and Adjusted EBITDA Guidance; Increases TEPEZZA and KRYSTEXXA Peak Annual Net Sales Expectations
Published: 2022-11-02 (Crawled : 12:20) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: 7.63%
H: 6.84%
C: 3.43%
sales krystexxa therapeutics tepezza financial
Horizon Therapeutics plc to Release First-Quarter 2022 Financial Results and Host Webcast on May 4, 2022
Published: 2022-04-14 (Crawled : 13:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: -0.16%
H: 1.73%
C: 1.21%
therapeutics results
Horizon Therapeutics plc Reports Fourth-Quarter 2021 and Full-Year 2021 Financial Results; Announces Full-Year 2022 Guidance
Published: 2022-03-01 (Crawled : 15:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: 3.13%
H: 0.0%
C: 0.0%
financial results ces therapeutics report results
Horizon Therapeutics plc to Release Fourth-Quarter and Full-Year 2021 Financial Results and Host Webcast on March 1, 2022
Published: 2022-02-07 (Crawled : 14:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: 1.54%
H: 2.15%
C: 1.12%
financial results therapeutics results
Horizon Therapeutics plc Reports Record Third-Quarter 2021 Financial Results; Increasing Full-Year 2021 Net Sales and Adjusted EBITDA Guidance
Published: 2021-11-03 (Crawled : 12:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: -6.31%
H: 6.02%
C: 4.29%
sales financial results results
Horizon Therapeutics plc to Release Third-Quarter 2021 Financial Results and Host Webcast on Nov. 3, 2021
Published: 2021-10-11 (Crawled : 13:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: -0.13%
H: 1.16%
C: -0.52%
financial results results
Horizon Therapeutics plc Reports First-Quarter 2021 Financial Results; Updating Full-Year 2021 Net Sales Guidance and Full-Year Adjusted EBITDA Guidance to Incorporate Recently Acquired Viela Bio, Inc.
Published: 2021-05-05 (Crawled : 12:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: -1.63%
H: 3.01%
C: 0.06%
sales financial results acquired dating results
Horizon Therapeutics plc to Release Fourth-Quarter and Full-Year 2020 Financial Results and Host Webcast on Feb. 24, 2021
Published: 2021-02-03 (Crawled : 16:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: -1.24%
H: 3.08%
C: 0.35%
results financial results
Horizon Therapeutics plc Provides Preliminary 2020 Financial Results, Exceeding Full-Year 2020 Net Sales and Adjusted EBITDA Guidance; Provides Update on TEPEZZA® (teprotumumab-trbw) Supply and New KRYSTEXXA® (pegloticase injection) Trials
Published: 2021-01-11 (Crawled : 15:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: -1.41%
H: 0.65%
C: 0.34%
injection results sales trial
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.